Literature DB >> 24446664

2,4-Diaminothienopyrimidines as orally active antimalarial agents.

Diego González Cabrera1, Claire Le Manach, Frederic Douelle, Yassir Younis, Tzu-Shean Feng, Tanya Paquet, Aloysius T Nchinda, Leslie J Street, Dale Taylor, Carmen de Kock, Lubbe Wiesner, Sandra Duffy, Karen L White, K Mohammed Zabiulla, Yuvaraj Sambandan, Sridevi Bashyam, David Waterson, Michael J Witty, Susan A Charman, Vicky M Avery, Sergio Wittlin, Kelly Chibale.   

Abstract

A novel series of 2,4-diaminothienopyrimidines with potential as antimalarials was identified from whole-cell high-throughput screening of a SoftFocus ion channel library. Synthesis and structure-activity relationship studies identified compounds with potent antiplasmodial activity and low in vitro cytotoxicity. Several of these analogues exhibited in vivo activity in the Plasmodium berghei mouse model when administered orally. However, inhibition of the hERG potassium channel was identified as a liability for this series.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24446664     DOI: 10.1021/jm401760c

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]-N-[(piperidin-4-yl)methyl]methanamine (MMV019918) and analogues.

Authors:  Alessandra Vallone; Sarah D'Alessandro; Simone Brogi; Margherita Brindisi; Giulia Chemi; Gloria Alfano; Stefania Lamponi; Soon Goo Lee; Joseph M Jez; Karin J M Koolen; Koen J Dechering; Simona Saponara; Fabio Fusi; Beatrice Gorelli; Donatella Taramelli; Silvia Parapini; Reto Caldelari; Giuseppe Campiani; Sandra Gemma; Stefania Butini
Journal:  Eur J Med Chem       Date:  2018-03-10       Impact factor: 6.514

2.  Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humans.

Authors:  Nicholas A Malmquist; Sandeep Sundriyal; Joachim Caron; Patty Chen; Benoit Witkowski; Didier Menard; Rossarin Suwanarusk; Laurent Renia; Francois Nosten; María Belén Jiménez-Díaz; Iñigo Angulo-Barturen; María Santos Martínez; Santiago Ferrer; Laura M Sanz; Francisco-Javier Gamo; Sergio Wittlin; Sandra Duffy; Vicky M Avery; Andrea Ruecker; Michael J Delves; Robert E Sinden; Matthew J Fuchter; Artur Scherf
Journal:  Antimicrob Agents Chemother       Date:  2014-11-24       Impact factor: 5.191

3.  Development of a Photo-Cross-Linkable Diaminoquinazoline Inhibitor for Target Identification in Plasmodium falciparum.

Authors:  Alexandra S Lubin; Ainoa Rueda-Zubiaurre; Holly Matthews; Hella Baumann; Fabio R Fisher; Julia Morales-Sanfrutos; Kate S Hadavizadeh; Flore Nardella; Edward W Tate; Jake Baum; Artur Scherf; Matthew J Fuchter
Journal:  ACS Infect Dis       Date:  2018-02-05       Impact factor: 5.084

4.  Identification and prioritization of novel anti-Wolbachia chemotypes from screening a 10,000-compound diversity library.

Authors:  Kelly L Johnston; Darren A N Cook; Neil G Berry; W David Hong; Rachel H Clare; Megan Goddard; Louise Ford; Gemma L Nixon; Paul M O'Neill; Stephen A Ward; Mark J Taylor
Journal:  Sci Adv       Date:  2017-09-27       Impact factor: 14.136

Review 5.  Discovery of the Hedgehog Pathway Inhibitor Pipinib that Targets PI4KIIIß.

Authors:  Lea Kremer; Elisabeth Hennes; Alexandra Brause; Andrei Ursu; Lucas Robke; Hideaki T Matsubayashi; Yuta Nihongaki; Jana Flegel; Ivana Mejdrová; Jan Eickhoff; Matthias Baumann; Radim Nencka; Petra Janning; Susanne Kordes; Hans R Schöler; Jared Sterneckert; Takanari Inoue; Slava Ziegler; Herbert Waldmann
Journal:  Angew Chem Int Ed Engl       Date:  2019-10-04       Impact factor: 15.336

6.  Design, synthesis, crystal structure and anti-plasmodial evaluation of tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives.

Authors:  Kavita Pal; Md Kausar Raza; Jenny Legac; Md Ataur Rahman; Shoaib Manzoor; Philip J Rosenthal; Nasimul Hoda
Journal:  RSC Med Chem       Date:  2021-05-18

7.  2,4-Diaminothieno[3,2-d]pyrimidines, a new class of anthelmintic with activity against adult and egg stages of whipworm.

Authors:  Frederick A Partridge; Ruth Forman; Nicky J Willis; Carole J R Bataille; Emma A Murphy; Anwen E Brown; Narinder Heyer-Chauhan; Bruno Marinič; Daniel J C Sowood; Graham M Wynne; Kathryn J Else; Angela J Russell; David B Sattelle
Journal:  PLoS Negl Trop Dis       Date:  2018-07-11

Review 8.  Thienopyrimidine: A Promising Scaffold to Access Anti-Infective Agents.

Authors:  Prisca Lagardère; Cyril Fersing; Nicolas Masurier; Vincent Lisowski
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-27

9.  A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.

Authors:  Henriette Bosson-Vanga; Nicolas Primas; Jean-François Franetich; Catherine Lavazec; Lina Gomez; Kutub Ashraf; Maurel Tefit; Valérie Soulard; Nathalie Dereuddre-Bosquet; Roger Le Grand; Mélanie Donnette; Romain Mustière; Nadia Amanzougaghene; Shahin Tajeri; Peggy Suzanne; Aurélie Malzert-Fréon; Sylvain Rault; Patrice Vanelle; Sébastien Hutter; Anita Cohen; Georges Snounou; Pierre Roques; Nadine Azas; Prisca Lagardère; Vincent Lisowski; Nicolas Masurier; Michel Nguyen; Lucie Paloque; Françoise Benoit-Vical; Pierre Verhaeghe; Dominique Mazier
Journal:  Microbiol Spectr       Date:  2021-09-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.